B

Biovie (BIVI)

$000.00 0.00% ($0.00)

Today
Week
Month
Year
5 Year
YTD

baraka

getbaraka.com

About Biovie (BIVI)

BioVie Inc. is a clinical stage biotechnology company engaged in the discovery, development and commercialization of therapies targeting life-threatening complications of liver cirrhosis. The Company's initial disease target is ascites a condition im... Read more

Open
USD0.91
High
USD1.31
Low
USD0.88
52 Week High
USD7.50
Monthly Return
27.10%
Revenue
--

Daily Vol.
8.96M
Avg. Daily Vol.
608.45k
Market Cap.
16M
52 Week Low
0.62
Annual Return
-75.80%

Stock News

Warren Buffett to step down as Berkshire CEO at year-end

Warren Buffett to step down as Berkshire CEO at year-end

MarketWatch

How Capital One can get an even bigger payoff from its Discover purchase

How Capital One can get an even bigger payoff from its Discover purchase

CNBC

Bank of the James Financial Group First Quarter 2025 Earnings: EPS: US$0.18 (vs US$0.48 in 1Q 2024)

Bank of the James Financial Group First Quarter 2025 Earnings: EPS: US$0.18 (vs US$0.48 in 1Q 2024)

Yahoo

Brain health experts' top 3 tips for lowering your risk of dementia, stroke and depression—all at the same time

Brain health experts' top 3 tips for lowering your risk of dementia, stroke and depression—all at the same time

CNBC

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.

Build Your Long Term Wealth

Build Your Long Term Wealth

A modern investment app with fair pricing.

Top Movers

This list tracks the stocks with the most upwards (top gainers) and downwards (top losers) movement in price from the previous day.

Not sure which stock to invest in?

Not sure which stock to invest in?

Get access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.